What is IGF-1 LR3?
IGF-1 LR3 (Long R3 IGF-I) is an analogue of insulin-like growth factor 1 that is usually produced for biochemical studies (Kohler 2010). Published work on LR3 itself is thin, so this page says what the literature shows and where it is silent. Stackpure supplies it for laboratory research only.
What the literature says
A case report describes identifying His-tagged Long-R3-IGF-I in a black-market injection vial. The authors note that His-tags are added during synthesis for purification and are normally removed, and that the effects of the tagged product in humans are unknown (Kohler 2010). A 2026 review of performance-enhancing products marketed as "research compounds" lists IGF-1 LR3 among growth hormone and IGF-1 axis agents. It reports endocrine and metabolic disturbances, fluid retention, musculoskeletal symptoms and injection-site reactions across the group, and states there is no regulatory approval for physique or performance indications and uncertainty about product composition in unregulated supply chains (Dominikowski 2026).
| Finding | Model | Source |
|---|---|---|
| His-tagged Long-R3-IGF-I identified in a black-market vial; human effects of the tagged product unknown | Case report, mass spectrometry | Kohler 2010 |
| GH-IGF-1 axis "research compounds" including IGF-1 LR3 have no regulatory approval for performance use; composition uncertain in unregulated supply | Clinical review | Dominikowski 2026 |
| IGFs and small intestinal cell growth and development | Review of IGF biology | MacDonald 1999 |
What the sources do not show
- The sources checked do not report receptor binding, potency or satellite cell data for LR3, so the earlier satellite cell activation claims are not repeated here.
- No source checked gives a half-life or dose, and Stackpure does not give dosing guidance.
- Purity and identity verification matter for this class of product. See the certificate of analysis on each batch.
Related research products and tools
- IGF-1 LR3 peptide vial
- IGF-1 LR3 nasal spray
- MGF research overview
- Peptide reconstitution calculator
Frequently Asked Questions
What is IGF-1 LR3?
An analogue of insulin-like growth factor 1 that is usually produced for biochemical studies (Kohler 2010).
Is IGF-1 LR3 approved?
A 2026 review states there is no regulatory approval for performance or physique indications for these research compounds (Dominikowski 2026).
Why does verification matter?
A case report found a tagged form in a black-market vial, showing product identity can differ from the label (Kohler 2010).
Key References
- Kohler M, et al. Detection of His-tagged Long-R3-IGF-I in a black market product. Growth Horm IGF Res. 2010. PubMed 20675162
- Dominikowski T, et al. The emerging landscape of performance-enhancing peptides modulating the GH-IGF1 axis. Front Endocrinol. 2026. PubMed 42395176
- MacDonald RS. The role of insulin-like growth factors in small intestinal cell growth and development. Horm Metab Res. 1999. PubMed 10226789
For research use only. Not for human consumption.